Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0000950170-25-114325

Director bought 3,500 shares at $22.60 ($79,100)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Wendy B. Director 2025-09-11 Purchase +3,500 $22.60 $79,100 9,500 D
Open-market purchases · 3,500 sh · avg $22.60 · $79,100
Loading xslF345X05/ownership.xml…